A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

This study is currently recruiting participants.
Verified April 2014 by Tesaro, Inc.
Sponsor:
Collaborators:
European Network of Gynaecological Oncological Trial Groups (ENGOT)
FORCE Facing our Risk of Cancer Empowered
Information provided by (Responsible Party):
Tesaro, Inc.
ClinicalTrials.gov Identifier:
NCT01847274
First received: April 11, 2013
Last updated: April 2, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)